Established in May 2016, The AMR Centre is a key part of the UK’s response to the global threat from Antimicrobial Resistance. Based at Alderley Park, The AMR Centre is a joint private-public initiative to support/accelerate the development of new antibiotics and diagnostics through a fully integrated development capability, offering translational R&D from pre-clinical hits through to clinical proof of concept.
The AMR Centre is proud to be part of the CARB-X international consortium.
Breaking News
AMR Centre Medivir deal targets ‘superbug’ time-bomb
Microbiotix and The AMR Centre Announce Co-Development Agreement Targeting Drug Resistant P. aeruginosa in Critically Ill Pneumonia Patients
Microbiotix and AMR Centre Announce Co-Development Agreement
Microbiotix and The AMR Centre Announce Co-Development Agreement Targeting Drug Resistant P. aeruginosa in Critically Ill Pneumonia Patients
AMR Centre moving to new laboratories in October
The AMR Centre has signed an agreement with Alderley Park to take on some new laboratories, which will be available from early November….more details to follow.
Latest News
AMR Centre Medivir deal targets ‘superbug’ time-bomb
Microbiotix and The AMR Centre Announce Co-Development Agreement Targeting Drug Resistant...
Microbiotix and AMR Centre Announce Co-Development Agreement
Microbiotix and The AMR Centre Announce Co-Development Agreement Targeting Drug Resistant...
AMR Centre moving to new laboratories in October
The AMR Centre has signed an agreement with Alderley Park to take on some new...
Dr. Pete Jackson on The AMR Centre and the O’Neill Review
The AMR Centre’s Executive Chairman, Dr. Pete Jackson, explains what The AMR Centre...
Dr Peter Jackson addresses the ON Helix conference
More work is required to try and combat the spread of diseases that are resistant to...
AMR Centre attends Innovation Week
The AMR Centre is delighted to have played a part during the recent Innovation Week,...
Call To Action
The AMR Centre is pleased to support a Call to Action to the G20 to commit investment in...
CARB-X injects up to $48 million
CARB-X injects up to $48 million to accelerate first Powered by CARB-X portfolio of drug...
Centre for Antimicrobial Pharmacodynamics
Professor William Hope of Liverpool University, a member of The AMR Centre’s Scientific...